1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends

Antiemetic Drugs: World Industry and Market Analysis 2014-2024

  • May 2014
  • 121 pages
  • Visiongain
Report ID: 2200868

Summary

Table of Contents

Please note: The license is valid for 12 months from the date the report is sent.


Report Details

Treatments for nausea and vomiting – explore business trends, R&D, and revenue forecasts
What’s the future of treating nausea and vomiting? For those medicines you get sales predictions, also exploring research and development. Those treatments hold high potential. There you assess results, progress, therapies, and opportunities.
Visiongain’s new report forecasts those revenues to 2024 at overall world market, submarket, product, and national level. Discover business potentials – trends, technologies, and new drugs.
Read on to explore anti-nausea and anti-vomiting therapies, seeing their potential revenue.

Forecasts to 2024 and other analyses explain and predict that pharma market

Why miss data you need? Why struggle to find it? Instead our report gives you revenue forecasts to 2024 for those pharmaceuticals. There find results, growth rates, market shares, and discussions.
Also you explore research and development (R&D). That study gives 41 tables, 48 charts, and an interview with a company. There find how you could benefit your authority and save time, staying ahead.
That study lets you assess the future of treating nausea and vomiting – especially in cancer treatment – exploring rising needs and demands. You find where opportunities and money lie. See, from 2014, where best selling prospects exist.
And the following sections show how that new investigation benefits your research, analyses and decisions.

Forecasting of that world market and its main segments

In our report you discover overall world revenue to 2024 for antiemetic medicines, with discussions.
You also find individual revenue predictions to 2024 for four submarkets at world level – drug classes:
- 5-HT3 antagonists
- Cannabinoids
- Dopamine antagonists
- Other agents (grouped).
There you assess outlooks for expansion in trade, hearing where you could gain. That work investigates therapies, uses, and rising sales. Our study also explores competition.
There you hear what’s happening for developers, producers, and sellers of antiemetic agents, understanding challenges, trends, and rising sales.
That work also splits its overall world market into products.

Predictions of leading treatments’ sales

How will drugs perform to 2024 at world level? Our study forecasts individual revenues of eight top products:
- Palonosetron
- Ondansetron
- Granisetron
- Dolasetron
- Dronabinol
- Nabilone
- Metoclopramide
- Domperidone.
There you find medicines and years with highest predicted sales. You also examine competitors. See, then, what’s happening, understanding, challenges, trends, and outlooks.
The new study also gives geographical revenue predictions.

Healthcare in national markets – what outlooks for that business?

In developed and developing countries, many opportunities for developers, producers, and sellers of antiemetic medicines will occur from 2014 to 2024. See where and how.
Our analyses show individual revenue forecasts to 2024 for 11 national markets:
- United States (US)
- Japan
- Germany, France, UK, Italy, and Spain (EU5)
- Brazil, Russia, India, and China (BRIC nations).
There you find countries with highest revenues, demand, and potential sales growth. Explore progress, needs and opportunities.
Also what events, challenges and advances in technology affect that industry and market? Our work shows you, discussing progress, policies, and R&D.

Market forces and issues – developments, challenges, and events influencing business

The report also explains issues, forces, and events affecting the antiemetic drugs industry and market from 2014, including these:
- Emesis and its pharmacological management – pathways and targets
- Future of serotonin (5-HT3) antagonists – existing and new therapies
- Demand for antiemetics in post-operativ

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Clinical Chemistry Reagents and Analyzers Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 75000
  • Industry report
  • May 2017
  • by Venture Planning Group

This new 74-country report from VPGMarketResearch.com is available by region, country, market segment, section, or individual test. Please contact Client Services at reports@vpgcorp.com or +1 212 564 ...

Immunodiagnostics Analyzers and Reagents Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 75000
  • Industry report
  • July 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

Cancer Diagnostics Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Emerging Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 52400
  • Industry report
  • May 2017
  • by Venture Planning Group

This new 74-country report from VPGMarketResearch.com is available by region, country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.